Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and TerminologyOliver Howes, John M. Kane, Richard Drake et al.|American Journal of Psychiatry|2016Cited by 1.1k
Psilocybin with psychological support for treatment-resistant depression: six-month follow-upRobin Carhart‐Harris, D.J. Nutt, Mark Bolstridge et al.|Psychopharmacology|2017Cited by 969
MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 InhibitionDavid Taylor, Ruth Luthi‐Carter|Journal of Neuroscience|2013Cited by 113
The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approachChristoffer Polcwiartek, Jimmi Nielsen, Benjamin Sneider et al.|Psychopharmacology|2015Cited by 71
Attention-deficit/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal studyAdrienne Y L Chan, Ian Chi Kei Wong, Tiantian Ma et al.|EClinicalMedicine|2023Cited by 70